Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	fascia adherens	XIRP1 TLN2 CTNNB1	5.31e-05	13	122	3	GO:0005916
Domain	SEA	MUC13 UMODL1 ADGRF5 MUC3A	1.58e-05	23	126	4	PS50024
Domain	SEA_dom	MUC13 UMODL1 ADGRF5 MUC3A	1.58e-05	23	126	4	IPR000082
Domain	GABAAa_rho_rcpt	GABRR1 GABRR2	4.52e-05	2	126	2	IPR008057
Domain	SEA	MUC13 ADGRF5 MUC3A	1.03e-04	14	126	3	SM00200
Domain	SEA	MUC13 UMODL1 ADGRF5	4.20e-04	22	126	3	PF01390
Domain	EGF_2	MUC13 SSPOP HEG1 TENM3 UMODL1 TNR MUC3A EPHB1	4.39e-04	265	126	8	PS01186
Domain	Anaphylatoxin_comp_syst	C4A C4B	4.46e-04	5	126	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	4.46e-04	5	126	2	IPR001840
Domain	VWA	COL12A1 ITGA2 ITGAL ITIH4	5.53e-04	56	126	4	PF00092
Domain	2FE2S_FER_2	AOX1 FDX1	6.65e-04	6	126	2	PS51085
Domain	2Fe-2S_ferredoxin-type	AOX1 FDX1	6.65e-04	6	126	2	IPR001041
Domain	Fer2	AOX1 FDX1	6.65e-04	6	126	2	PF00111
Domain	fn3	MYBPH COL12A1 UMODL1 PTPRO TNR EPHB1	8.12e-04	162	126	6	PF00041
Domain	ANATO	C4A C4B	9.27e-04	7	126	2	SM00104
Domain	RPEL	MRTFB PHACTR1	9.27e-04	7	126	2	PS51073
Domain	RPEL	MRTFB PHACTR1	9.27e-04	7	126	2	SM00707
Domain	ANAPHYLATOXIN_2	C4A C4B	9.27e-04	7	126	2	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B	9.27e-04	7	126	2	PS01177
Domain	ANATO	C4A C4B	9.27e-04	7	126	2	PF01821
Domain	RPEL	MRTFB PHACTR1	9.27e-04	7	126	2	PF02755
Domain	RPEL_repeat	MRTFB PHACTR1	9.27e-04	7	126	2	IPR004018
Domain	Anaphylatoxin/fibulin	C4A C4B	9.27e-04	7	126	2	IPR000020
Domain	EGF_3	MUC13 SSPOP HEG1 TENM3 UMODL1 TNR MUC3A	1.09e-03	235	126	7	PS50026
Domain	MacrogloblnA2_thiol-ester-bond	C4A C4B	1.23e-03	8	126	2	IPR019565
Domain	Thiol-ester_cl	C4A C4B	1.23e-03	8	126	2	PF10569
Domain	MacrogloblnA2_CS	C4A C4B	1.23e-03	8	126	2	IPR019742
Domain	WHTH_DNA-bd_dom	DVL1P1 FOXP2 RFX7 EIF3CL ELF2 ASCC3 FOXK1	1.29e-03	242	126	7	IPR011991
Domain	FN3	MYBPH COL12A1 UMODL1 PTPRO TNR EPHB1	1.61e-03	185	126	6	SM00060
Domain	EGF_1	MUC13 SSPOP HEG1 TENM3 UMODL1 TNR MUC3A	1.73e-03	255	126	7	PS00022
Domain	A2M	C4A C4B	1.96e-03	10	126	2	PF00207
Domain	A2M_N_2	C4A C4B	1.96e-03	10	126	2	IPR011625
Domain	A2M_comp	C4A C4B	1.96e-03	10	126	2	IPR011626
Domain	A2M_recep	C4A C4B	1.96e-03	10	126	2	PF07677
Domain	A2M_comp	C4A C4B	1.96e-03	10	126	2	PF07678
Domain	A2M_N	C4A C4B	1.96e-03	10	126	2	PF01835
Domain	A2M_N	C4A C4B	1.96e-03	10	126	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	C4A C4B	1.96e-03	10	126	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C4A C4B	1.96e-03	10	126	2	PS00477
Domain	A2M_N_2	C4A C4B	1.96e-03	10	126	2	PF07703
Domain	Macroglobln_a2	C4A C4B	1.96e-03	10	126	2	IPR001599
Domain	EGF-like_CS	MUC13 HEG1 TENM3 UMODL1 TNR MUC3A EPHB1	1.98e-03	261	126	7	IPR013032
Domain	VWFA	COL12A1 ITGA2 ITGAL ITIH4	2.30e-03	82	126	4	PS50234
Domain	FN3	MYBPH COL12A1 UMODL1 PTPRO TNR EPHB1	2.32e-03	199	126	6	PS50853
Domain	VWA	COL12A1 ITGA2 ITGAL ITIH4	2.51e-03	84	126	4	SM00327
Domain	Carbonic_anhydrase_a-class_CS	CA5B CA6	2.85e-03	12	126	2	IPR018338
Domain	AAA	WRNIP1 MCM4 NAV2 ASCC3 DNAH5	2.94e-03	144	126	5	SM00382
Domain	AAA+_ATPase	WRNIP1 MCM4 NAV2 ASCC3 DNAH5	2.94e-03	144	126	5	IPR003593
Domain	FN3_dom	MYBPH COL12A1 UMODL1 PTPRO TNR EPHB1	2.96e-03	209	126	6	IPR003961
Domain	-	AOX1 FDX1	3.90e-03	14	126	2	3.10.20.30
Domain	MS4A	MS4A6E MS4A8	3.90e-03	14	126	2	IPR030417
Domain	Beta-grasp_dom	AOX1 FDX1	3.90e-03	14	126	2	IPR012675
Domain	Carbonic_anhydrase_a-class	CA5B CA6	4.48e-03	15	126	2	IPR023561
Domain	ALPHA_CA_1	CA5B CA6	4.48e-03	15	126	2	PS00162
Domain	VWF_A	COL12A1 ITGA2 ITGAL ITIH4	4.54e-03	99	126	4	IPR002035
Domain	Integrin_alpha_C_CS	ITGA2 ITGAL	5.09e-03	16	126	2	IPR018184
Domain	SMAD_FHA_domain	KIF13B FOXK1 SMAD5	5.21e-03	52	126	3	IPR008984
Domain	EGF	MUC13 HEG1 TENM3 UMODL1 TNR MUC3A	5.24e-03	235	126	6	SM00181
Domain	EMI	SSPOP UMODL1	5.75e-03	17	126	2	PS51041
Domain	Carb_anhydrase	CA5B CA6	5.75e-03	17	126	2	PF00194
Domain	CarboxyPept-like_regulatory	CPM TENM3	5.75e-03	17	126	2	IPR008969
Domain	Carb_anhydrase	CA5B CA6	5.75e-03	17	126	2	SM01057
Domain	-	CA5B CA6	5.75e-03	17	126	2	3.10.200.10
Domain	C345C	C4A C4B	5.75e-03	17	126	2	SM00643
Domain	ALPHA_CA_2	CA5B CA6	5.75e-03	17	126	2	PS51144
Domain	Carbonic_anhydrase_a	CA5B CA6	5.75e-03	17	126	2	IPR001148
Domain	Integrin_alpha-2	ITGA2 ITGAL	6.44e-03	18	126	2	IPR013649
Domain	Terpenoid_cyclase/PrenylTrfase	C4A C4B	6.44e-03	18	126	2	IPR008930
Domain	INTEGRIN_ALPHA	ITGA2 ITGAL	6.44e-03	18	126	2	PS00242
Domain	Integrin_alpha2	ITGA2 ITGAL	6.44e-03	18	126	2	PF08441
Domain	Integrin_alpha	ITGA2 ITGAL	6.44e-03	18	126	2	IPR000413
Pubmed	Human transcription factor protein interaction networks.	NCOA6 SATB2 DDX31 FOXP2 VEZF1 RFX7 PABPC1 JMJD1C LIN9 ZFPM2 PRDM2 BRD8 MIDN YEATS4 MAGED2 SVIL RLIM ELF2 HERC1 SAP130 FOXK1 ZNF687 SMAD5	2.06e-09	1429	127	23	35140242
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR NCOA6 WRNIP1 MCM4 RFX7 PRDM2 EIF3CL BRD8 MAGED2 SVIL TLN2 ELF2 PCBP1 STAG2 ZNF687	1.65e-07	774	127	15	15302935
Pubmed	Transcriptional repression by FEZF2 restricts alternative identities of cortical projection neurons.	SATB2 FOXP2 ZFPM2 EPHB1	4.99e-07	18	127	4	34161768
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TPR ATF7 SATB2 FOXP2 WRNIP1 MCM4 JMJD1C LIN9 BRD8 YEATS4 CTNNB1 ANAPC7 SAP130 STAG2 FOXK1	5.99e-07	857	127	15	25609649
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA6 JMJD1C ELF2 SAP130 STAG2 FOXK1	6.31e-07	83	127	6	28794006
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA6 SATB2 FOXP2 RFX7 LIN9 PRDM2 YEATS4 ELF2 CTNNB1 FOXK1	7.10e-07	351	127	10	38297188
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ATF7 NCOA6 MCPH1 VEZF1 RFX7 JMJD1C LIN9 PRDM2 BRD8 YEATS4 ZBED4 ELF2 PCBP1 ANAPC7 SAP130 STAG2 FOXK1 ZNF687	1.17e-06	1294	127	18	30804502
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ATF7 NCOA6 SATB2 VEZF1 WRNIP1 MCM4 PABPC1 JMJD1C LIN9 PRDM2 ELF2 ANAPC7 SAP130 STAG2 FOXK1 ZNF687	2.84e-06	1103	127	16	34189442
Pubmed	Corticothalamic Projection Neuron Development beyond Subtype Specification: Fog2 and Intersectional Controls Regulate Intraclass Neuronal Diversity.	SATB2 FOXP2 ZFPM2 PCNX1	4.94e-06	31	127	4	27321927
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	TPR ZFAND5 PABPC1 MRTFB MAGED2 TLN2 CTNNB1 FOXK1	6.62e-06	267	127	8	33417871
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA6 WRNIP1 JMJD1C LIN9 BRD8 ELF2 SAP130 FOXK1	6.81e-06	268	127	8	33640491
Pubmed	Satb2 Regulates the Differentiation of Both Callosal and Subcerebral Projection Neurons in the Developing Cerebral Cortex.	SATB2 FOXP2 ZFPM2	1.02e-05	12	127	3	25037921
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	1.32e-05	2	127	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	1.32e-05	2	127	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	1.32e-05	2	127	2	15998580
Pubmed	Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion.	HMOX1 VEGFA	1.32e-05	2	127	2	31264739
Pubmed	Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients.	HMOX1 VEGFA	1.32e-05	2	127	2	22849380
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	1.32e-05	2	127	2	19062096
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	1.32e-05	2	127	2	19933335
Pubmed	Mitigation of oxygen-induced retinopathy in α2β1 integrin-deficient mice.	ITGA2 VEGFA	1.32e-05	2	127	2	24917135
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	1.32e-05	2	127	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	1.32e-05	2	127	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	1.32e-05	2	127	2	12207352
Pubmed	The intercalated disk protein, mXinalpha, is capable of interacting with beta-catenin and bundling actin filaments [corrected].	XIRP1 CTNNB1	1.32e-05	2	127	2	17925400
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	1.32e-05	2	127	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	1.32e-05	2	127	2	22387014
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	1.32e-05	2	127	2	23749435
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	1.32e-05	2	127	2	23918728
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	1.32e-05	2	127	2	3037333
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	1.32e-05	2	127	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	1.32e-05	2	127	2	4216347
Pubmed	HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis.	HMOX1 VEGFA	1.32e-05	2	127	2	16999951
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	1.32e-05	2	127	2	6950384
Pubmed	Gene-based interaction analysis shows GABAergic genes interacting with parenting in adolescent depressive symptoms.	GABRR1 GABRR2	1.32e-05	2	127	2	28660714
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	1.32e-05	2	127	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	1.32e-05	2	127	2	8428773
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	1.32e-05	2	127	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	1.32e-05	2	127	2	21345967
Pubmed	β-catenin regulates FOXP2 transcriptional activity via multiple binding sites.	FOXP2 CTNNB1	1.32e-05	2	127	2	33284517
Pubmed	GABRR1 and GABRR2, encoding the GABA-A receptor subunits rho1 and rho2, are associated with alcohol dependence.	GABRR1 GABRR2	1.32e-05	2	127	2	19536785
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	1.32e-05	2	127	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	1.32e-05	2	127	2	2302180
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	1.32e-05	2	127	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	1.32e-05	2	127	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	1.32e-05	2	127	2	29080553
Pubmed	Different modes of endothelial-smooth muscle cell interaction elicit differential β-catenin phosphorylations and endothelial functions.	CTNNB1 SMAD5	1.32e-05	2	127	2	24449884
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	1.32e-05	2	127	2	6589636
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	1.32e-05	2	127	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	1.32e-05	2	127	2	17728371
Pubmed	Structure and organization of the C4 genes.	C4A C4B	1.32e-05	2	127	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	1.32e-05	2	127	2	6149581
Pubmed	The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.	C4A C4B	1.32e-05	2	127	2	12115608
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	1.32e-05	2	127	2	3542363
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	1.32e-05	2	127	2	2387317
Pubmed	Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.	C4A C4B	1.32e-05	2	127	2	16908004
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	1.32e-05	2	127	2	7365238
Pubmed	Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.	C4A C4B	1.32e-05	2	127	2	7391573
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	1.32e-05	2	127	2	17971360
Pubmed	Clinical features of patients with homozygous complement C4A or C4B deficiency.	C4A C4B	1.32e-05	2	127	2	29928053
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	1.32e-05	2	127	2	17971229
Pubmed	Opposite effects of prostaglandin-J2 on VEGF in normoxia and hypoxia: role of HIF-1.	HMOX1 VEGFA	1.32e-05	2	127	2	14715242
Pubmed	Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.	C4A C4B	1.32e-05	2	127	2	6881182
Pubmed	Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX.	HMOX1 VEGFA	1.32e-05	2	127	2	12716475
Pubmed	Partial C4 deficiency in juvenile idiopathic arthritis patients.	C4A C4B	1.32e-05	2	127	2	17921792
Pubmed	Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.	C4A C4B	1.32e-05	2	127	2	21880985
Pubmed	Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.	C4A C4B	1.32e-05	2	127	2	6978711
Pubmed	Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.	C4A C4B	1.32e-05	2	127	2	35898513
Pubmed	Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.	C4A C4B	1.32e-05	2	127	2	28873507
Pubmed	Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.	SATB2 CTNNB1	1.32e-05	2	127	2	28438615
Pubmed	Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.	C4A C4B	1.32e-05	2	127	2	276882
Pubmed	MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity.	MUC13 CTNNB1	1.32e-05	2	127	2	31427737
Pubmed	Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.	C4A C4B	1.32e-05	2	127	2	6832377
Pubmed	Recombination of two homologous MHC class III genes of the mouse (C4 and Slp) that accounts for the loss of testosterone dependence of sex-limited protein expression.	C4A C4B	1.32e-05	2	127	2	3794341
Pubmed	Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes.	C4A C4B	1.32e-05	2	127	2	22785613
Pubmed	Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis.	C4A C4B	1.32e-05	2	127	2	32691186
Pubmed	The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter.	C4A C4B	1.32e-05	2	127	2	8390682
Pubmed	Blocking heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer.	HMOX1 VEGFA	1.32e-05	2	127	2	26822586
Pubmed	Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp).	C4A C4B	1.32e-05	2	127	2	3902619
Pubmed	HMOX1 Participates in Pre-Eclampsia by Regulating the Proliferation, Apoptosis, and Angiogenesis Modulation Potential of Mesenchymal Stem Cells via VEGF.	HMOX1 VEGFA	1.32e-05	2	127	2	37573262
Pubmed	Structural polymorphism of murine C4 and its linkage to H-2.	C4A C4B	1.32e-05	2	127	2	7373044
Pubmed	Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression.	CTNNB1 VEGFA	1.32e-05	2	127	2	22034877
Pubmed	The chemical structure of the C4d fragment of the human complement component C4.	C4A C4B	1.32e-05	2	127	2	3696167
Pubmed	Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups.	C4A C4B	1.32e-05	2	127	2	1357031
Pubmed	Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s.	C4A C4B	1.32e-05	2	127	2	16098595
Pubmed	Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.	CTNNB1 VEGFA	1.32e-05	2	127	2	27449032
Pubmed	The N-terminal domain of human GABA receptor rho1 subunits contains signals for homooligomeric and heterooligomeric interaction.	GABRR1 GABRR2	1.32e-05	2	127	2	9153229
Pubmed	Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura.	C4A C4B	1.32e-05	2	127	2	15787745
Pubmed	Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study.	C4A C4B	1.32e-05	2	127	2	30026462
Pubmed	A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B.	C4A C4B	1.32e-05	2	127	2	6559257
Pubmed	Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects.	C4A C4B	1.32e-05	2	127	2	34299197
Pubmed	Assessment of complement C4 gene copy number using the paralog ratio test.	C4A C4B	1.32e-05	2	127	2	20506482
Pubmed	Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: association with systemic lupus erythematosus in southwest Han Chinese.	C4A C4B	1.32e-05	2	127	2	12480675
Pubmed	Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus.	C4A C4B	1.32e-05	2	127	2	26800705
Pubmed	VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo.	HMOX1 VEGFA	1.32e-05	2	127	2	17264168
Pubmed	Murine complement C4 is not required for experimental autoimmune encephalomyelitis.	C4A C4B	1.32e-05	2	127	2	15390104
Pubmed	Elimination of the rho1 subunit abolishes GABA(C) receptor expression and alters visual processing in the mouse retina.	GABRR1 GABRR2	1.32e-05	2	127	2	12019334
Pubmed	HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.	HEG1 CTNNB1	1.32e-05	2	127	2	31278131
Pubmed	Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein.	C4A C4B	1.32e-05	2	127	2	1699796
Pubmed	Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp.	C4A C4B	1.32e-05	2	127	2	2997024
Pubmed	Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences.	C4A C4B	1.32e-05	2	127	2	3624865
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	7.52e-04	9	84	2	1234
GeneFamily	Fibronectin type III domain containing	MYBPH COL12A1 PTPRO TNR EPHB1	8.97e-04	160	84	5	555
GeneFamily	Cadherin related	DCHS2 PCDH15	2.77e-03	17	84	2	24
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA2 ITGAL	3.11e-03	18	84	2	1160
GeneFamily	Carbonic anhydrases	CA5B CA6	3.11e-03	18	84	2	460
GeneFamily	CD molecules\|Membrane spanning 4-domains	MS4A6E MS4A8	3.11e-03	18	84	2	958
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRR1 GABRR2	3.46e-03	19	84	2	563
GeneFamily	CD molecules\|Mucins	MUC13 MUC3A	4.23e-03	21	84	2	648
Coexpression	GSE3982_DC_VS_MAC_DN	KIF13B INCENP UBR7 HEG1 FDX1 CD101 NAV2 PCBP1 PHACTR1	5.22e-07	200	125	9	M5460
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	KIF13B FOXP2 CPM ITGA2 SVIL ELF2 ASCC3 DNAH5	1.57e-06	169	125	8	M39230
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN	ZFAND5 JMJD1C HEG1 USF3 RLIM CTNNB1 ASCC3 VEGFA PHACTR1	7.37e-06	276	125	9	M41128
Coexpression	CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE	XIRP1 FREM2 HEG1 ZNF827 SVIL PARM1 VEGFA	2.49e-05	179	125	7	M39308
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FOXP2 CPM NHSL1 FREM2 NAV2 ADGRF5 PARM1 PHACTR1	7.93e-08	191	127	8	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	FREM2 SVIL NAV2 ADGRF5 DNAH5 PARM1 PHACTR1	9.03e-07	181	127	7	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	FOXP2 FREM2 ADGRF5 DNAH5 PARM1 VEGFA PHACTR1	1.16e-06	188	127	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 CPM PABPC1 NALCN ECSCR CD101 SVIL	1.25e-06	190	127	7	0eef5a8bd88ef8a25a67d9dd522d9472fa4b3d2f
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DPB1 CPM PABPC1 NALCN ECSCR CD101 SVIL	1.25e-06	190	127	7	2724e8f375d8d9f5f2a77444e0491af264babac5
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DPB1 CPM PABPC1 NALCN ECSCR CD101 SVIL	1.25e-06	190	127	7	11fbd4e9f02750354b3aadf30edc991f8d4f8f41
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 CPM PABPC1 NALCN ECSCR CD101 SVIL	1.25e-06	190	127	7	148d43dd72e2e22b2cd68e17fedae6bd98b32aee
ToppCell	Severe_COVID-19-Myeloid-TRAM1\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	HLA-DPB1 CPM PABPC1 NALCN ECSCR CD101 SVIL	1.29e-06	191	127	7	bd641aab36276dd952a7265ee79ba455b38d8e6b
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	FOXP2 CPM FREM2 NAV2 ADGRF5 PARM1 PHACTR1	1.34e-06	192	127	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FOXP2 CPM FREM2 NAV2 ADGRF5 PARM1 PHACTR1	1.34e-06	192	127	7	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FOXP2 CPM NHSL1 FREM2 ADGRF5 PARM1 PHACTR1	1.34e-06	192	127	7	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ITGA2 CFAP65 CFAP100 MRTFB EFCAB12 MS4A8 DNAH5	1.39e-06	193	127	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SATB2 FOXP2 CPM SVIL MAML2 DNAH5 PHACTR1	1.44e-06	194	127	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	Bronchial_Biopsy-Immune-Dendritic_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	HLA-DPB1 ZFAND5 PABPC1 JMJD1C MIDN VEGFA PHACTR1	1.70e-06	199	127	7	be916332291ea48e244c05ab1855f9fcd718ac54
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	ITGA2 JMJD1C HEG1 MRTFB NR5A2 ADGRF5 SMAD5	1.76e-06	200	127	7	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SATB2 CFAP65 FREM2 MS4A8 C1QTNF6 EPHB1	8.52e-06	167	127	6	5accd0bc7c95089feb2c09376d12cd8bd3773775
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ZFPM2 TENM3 NALCN NAV2 PARM1	9.44e-06	170	127	6	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ZFPM2 TENM3 NALCN NAV2 PARM1	9.44e-06	170	127	6	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	COL12A1 HEG1 NAV2 ADGRF5 VEGFA PHACTR1	9.44e-06	170	127	6	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HEG1 ECSCR NR5A2 SLC13A5 ADGRF5 CTNNB1	1.08e-05	174	127	6	3d4c05ea5719ca65e85d1f15198453034791087c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL12A1 ZFPM2 NALCN NAV2 TLN2 MAML2	1.11e-05	175	127	6	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	1.23e-05	178	127	6	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 COL12A1 ZFPM2 TENM3 NALCN NAV2	1.39e-05	182	127	6	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 COL12A1 ZFPM2 TENM3 NALCN NAV2	1.39e-05	182	127	6	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FOXP2 CPM FREM2 ADGRF5 PARM1 PHACTR1	1.43e-05	183	127	6	6847c1252d6bb105524f812658112517fd351eab
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 SSPOP FREM2 PCDH15 TLN2 DNAH5	1.48e-05	184	127	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 SSPOP FREM2 PCDH15 TLN2 DNAH5	1.48e-05	184	127	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 SSPOP FREM2 PCDH15 TLN2 DNAH5	1.48e-05	184	127	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	343B-Fibroblasts-Fibroblast-E-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZNF613 AOX1 ZFPM2 KRBOX1 WASHC5 TLN2	1.57e-05	186	127	6	1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STK32A MRTFB ECSCR ADGRF5 PARM1 VEGFA	1.57e-05	186	127	6	9c7924875f70420720149287c500b4dfa8d24673
ToppCell	343B-Fibroblasts-Fibroblast-E\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZNF613 AOX1 ZFPM2 KRBOX1 WASHC5 TLN2	1.57e-05	186	127	6	59db239f1864a5d4f1570c93219dbd7ac5b6db35
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MS4A6E HLA-DPB1 IFI35 NALCN PTPRO CD101	1.57e-05	186	127	6	cb7df8da6478b96955f3ef1394a0655ec8061bba
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ZNF407 JMJD1C PRDM2 PCNX1 CTNNB1 HERC1	1.67e-05	188	127	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	FOXP2 STK32A NAV2 ADGRF5 DNAH5 PARM1	1.67e-05	188	127	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	COPD-Epithelial-Mesothelial\|Epithelial / Disease state, Lineage and Cell class	AOX1 ZFPM2 HEG1 TENM3 C4A C4B	1.67e-05	188	127	6	159d63ecc3653a7449fc6acefd6ef0464845260e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FOXP2 CPM ITGA2 ARFGAP3 NAV2 PHACTR1	1.77e-05	190	127	6	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FOXP2 CPM ITGA2 ARFGAP3 NAV2 PHACTR1	1.77e-05	190	127	6	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	XIRP1 WRNIP1 ITIH4 MAGED2 C4B PARM1	1.77e-05	190	127	6	140aca04c044cd7a93f81ff1631b00b5216d2cb1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 ZFPM2 TENM3 NALCN NAV2 PARM1	1.83e-05	191	127	6	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 ITGA2 ECSCR RRH MS4A8 TLN2	1.83e-05	191	127	6	df8cdbc26443e55a203cbafa21b0952a2a55b9bf
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FOXP2 CPM NHSL1 FREM2 ADGRF5 PARM1	1.83e-05	191	127	6	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FOXP2 CPM FREM2 ADGRF5 PARM1 PHACTR1	1.83e-05	191	127	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	FOXP2 CPM STK32A FREM2 ADGRF5 PARM1	1.83e-05	191	127	6	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	FOXP2 CPM FREM2 NAV2 ADGRF5 PHACTR1	1.83e-05	191	127	6	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FOXP2 CPM FREM2 ADGRF5 PARM1 PHACTR1	1.83e-05	191	127	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 ZFPM2 TENM3 NALCN NAV2 PARM1	1.83e-05	191	127	6	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AOX1 ITGA2 ZFPM2 TENM3 PCDH15 NAV2	1.83e-05	191	127	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	wk_20-22-Epithelial-Distal_epithelial_progenitor\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CPM ITGA2 NHSL1 FREM2 ADGRF5 PARM1	1.88e-05	192	127	6	fa2420d6117d4800f60ef6a24bcf8bf54593cd1f
ToppCell	wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CPM ITGA2 NHSL1 FREM2 ADGRF5 PARM1	1.88e-05	192	127	6	87b60014202633a4f6d19b09a5dd9276c2edecfb
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	FOXP2 CPM FREM2 ADGRF5 PARM1 PHACTR1	1.88e-05	192	127	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AOX1 ITGA2 ZFPM2 TENM3 PCDH15 NAV2	1.88e-05	192	127	6	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	11.5-Airway-Epithelial-Bud_tip_progenitor\|Airway / Age, Tissue, Lineage and Cell class	FOXP2 CPM ITGA2 NHSL1 ADGRF5 PARM1	1.94e-05	193	127	6	f0a07bb221a497a9f7cc706045d5205269be4515
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	C1orf141 FREM2 MS4A8 ADGRF5 DNAH5 PARM1	1.94e-05	193	127	6	bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FOXP2 CPM FREM2 NAV2 ADGRF5 PHACTR1	1.94e-05	193	127	6	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	COPD-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	KIF13B HLA-DPB1 ZFAND5 CPM NHSL1 PCNX1	1.99e-05	194	127	6	7d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	1.99e-05	194	127	6	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TOM1 ZFAND5 CPM HMOX1 PABPC1 MIDN	1.99e-05	194	127	6	a94f9f7179a5733e3c378ff8b337e288785433a1
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FOXP2 CPM FREM2 ADGRF5 PARM1 PHACTR1	1.99e-05	194	127	6	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	2.05e-05	195	127	6	cfcf554b436083179dea1d6fd6e3a800ea2430fe
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	FOXP2 AOX1 ZFPM2 NAV2 TLN2 MAML2	2.05e-05	195	127	6	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FOXP2 NAV2 ADGRF5 DNAH5 PARM1 PHACTR1	2.05e-05	195	127	6	9406866f99555198a9be311fbd65751b70f35446
ToppCell	wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_late\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FOXP2 CPM ITGA2 NHSL1 ADGRF5 PARM1	2.11e-05	196	127	6	75e9e430a4f55ef10f2e3132afa690fc8bfaff83
ToppCell	wk_15-18-Epithelial-Distal_epithelial_progenitor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	FOXP2 CPM ITGA2 NHSL1 ADGRF5 PARM1	2.11e-05	196	127	6	00bef0e47739932fd1da109cd607de0789d14ca5
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FOXP2 CPM FREM2 ADGRF5 PARM1 PHACTR1	2.24e-05	198	127	6	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FOXP2 CPM FREM2 ADGRF5 PARM1 PHACTR1	2.24e-05	198	127	6	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	3'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPM MUC13 ARFGAP3 TLN2 CTNNB1 PARM1	2.24e-05	198	127	6	7ad7726fc405806b1d7824f58548073ea5e0c70b
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPM MUC13 ARFGAP3 TLN2 CTNNB1 PARM1	2.24e-05	198	127	6	1fbec311f2c987ca90a023a5989128c05aa12d5c
ToppCell	3'-Adult-Distal_Rectal-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPM MUC13 ARFGAP3 TLN2 CTNNB1 PARM1	2.24e-05	198	127	6	ceede961ad9af6a3159db7efaa5087bf38aafc2d
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPM MUC13 ARFGAP3 TLN2 CTNNB1 PARM1	2.24e-05	198	127	6	4f26a60e99f42343e5af7221723e108a1a1b7827
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPM NHSL1 FREM2 ADGRF5 PARM1 PHACTR1	2.30e-05	199	127	6	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPM NHSL1 FREM2 ADGRF5 PARM1 PHACTR1	2.30e-05	199	127	6	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPM NHSL1 FREM2 ADGRF5 PARM1 PHACTR1	2.30e-05	199	127	6	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPM NHSL1 FREM2 ADGRF5 PARM1 PHACTR1	2.30e-05	199	127	6	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	COPD-Myeloid-Macrophage\|COPD / Disease state, Lineage and Cell class	MS4A6E HLA-DPB1 ZFAND5 CPM NHSL1 VEGFA	2.30e-05	199	127	6	4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TPR ZFAND5 RLIM DNAH5 STAG2 SMAD5	2.30e-05	199	127	6	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Biopsy_Control_(H.)-Epithelial-Ciliated\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	2.37e-05	200	127	6	9ae434c78e08adf95da49c85616e3ca72d1227bf
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL12A1 HEG1 MRTFB NR5A2 ADGRF5 SMAD5	2.37e-05	200	127	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	2.37e-05	200	127	6	52aef65f01b06cd98056f17977efe525aee6eb6f
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	2.37e-05	200	127	6	55c148238d5c80c1faa3428a917ae8075be2c145
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	2.37e-05	200	127	6	31d75c26055177d656df1fbb10b764cebd61e122
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	2.37e-05	200	127	6	85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	2.37e-05	200	127	6	e1dce91c6c531bb212002a14705e496d77ad3490
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	C1orf141 CFAP65 CFAP100 EFCAB12 MS4A8 DNAH5	2.37e-05	200	127	6	12bc7d95c4166d12487081a76d210b7abe5991b0
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	COL12A1 FOXP2 IFI35 ZFPM2 SVIL	2.43e-05	120	127	5	2b7596946f9268c4202348adf3069decd8313bb0
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O1-Trf\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GABRR2 MUC13 SSPOP LCTL	4.29e-05	68	127	4	31f9f6b4473970473f89b67643bb55dc332732d8
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GABRR2 MUC13 SSPOP LCTL	4.29e-05	68	127	4	91a500a68245a8a484a537aad2cc8b62ff4579f0
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GABRR2 MUC13 SSPOP LCTL	4.29e-05	68	127	4	a89cc6fb62f50ea4124b1a6b0b30cd7ceb52e408
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GABRR2 MUC13 SSPOP LCTL	4.29e-05	68	127	4	3d148bb49246c3fac9a1e864ecc5e15b29863c52
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6b\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SATB2 COL12A1 IFI35 ZFPM2 SVIL	5.09e-05	140	127	5	17005ca714ba03d7528fe7979ffb4654a46b666c
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYBPH COL12A1 FOXP2 ZFPM2 PHACTR1	7.06e-05	150	127	5	9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)\|Striatum / BrainAtlas - Mouse McCarroll V32	GABRR2 SSPOP PABPC1 LCTL	7.72e-05	79	127	4	239d34f40c3a96186231f3aabd41c4988af3f372
ToppCell	Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GABRR2 SSPOP PABPC1 LCTL	7.72e-05	79	127	4	eddad041c0bc6952d9c68a36bdd78f6d661f0e58
ToppCell	Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GABRR2 SSPOP PABPC1 LCTL	7.72e-05	79	127	4	4c9c3051cb8a9c39c6df20e3fe37242db4b44280
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf\|Striatum / BrainAtlas - Mouse McCarroll V32	GABRR2 SSPOP PABPC1 LCTL	7.72e-05	79	127	4	a60fcbb278ba629af922c53faf58e4d96c537b15
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1\|E18.5-samps / Age Group, Lineage, Cell class and subclass	NCOA6 SATB2 MCM4 MAGED2 ZNF687	9.30e-05	159	127	5	b4bc888e978b1b577721b891b0af6ba9a1607044
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CPM STK32A FREM2 PARM1 PHACTR1	9.30e-05	159	127	5	e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SSPOP ZFPM2 NALCN PTPRO VEGFA	9.30e-05	159	127	5	fd7db2f7328cfefdc3ada2af91006d5a91d137e1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SSPOP ZFPM2 NALCN PTPRO VEGFA	9.30e-05	159	127	5	aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SSPOP ZFPM2 NALCN PTPRO VEGFA	9.30e-05	159	127	5	8bbdef1e927f3130b578d7d7c5ff38bbe06fab63
ToppCell	tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	SATB2 HLA-DPB1 ITGAL HORMAD1 DNAH5	1.08e-04	164	127	5	60fe6bb86afaebd92590135f08f5434ce0d8d73c
Drug	baryta	TPR XIRP1 MCPH1 PACSIN1 SERPINA6 IFI35 YEATS4 ADSL	8.62e-07	136	125	8	CID000062392
Disease	vascular endothelial growth factor A, isoform 121 measurement	JMJD1C ZFPM2 VEGFA	5.55e-06	9	121	3	EFO_0020847
Disease	vascular endothelial growth factor A measurement	JMJD1C ZFPM2 VEGFA	1.44e-05	12	121	3	EFO_0010804
Disease	lactate measurement	WRNIP1 ZFPM2 TENM3 FDX1	1.98e-05	39	121	4	EFO_0007745
Disease	Retinal Vein Occlusion	ITGA2 VEGFA	4.99e-05	3	121	2	C0035328
Disease	Thrombosis of retinal vein	ITGA2 VEGFA	4.99e-05	3	121	2	C1527411
Disease	Primary microcephaly	MCPH1 CEP63 CTNNB1	9.78e-05	22	121	3	C0431350
Disease	neutrophil-activating peptide 2 measurement	JMJD1C ZFPM2	9.95e-05	4	121	2	EFO_0020606
Disease	intermediate coronary syndrome (is_implicated_in)	ITGA2 ITIH4	1.65e-04	5	121	2	DOID:8805 (is_implicated_in)
Disease	limb ischemia (implicated_via_orthology)	HMOX1 VEGFA	1.65e-04	5	121	2	DOID:0050852 (implicated_via_orthology)
Disease	DnaJ homolog subfamily B member 11 measurement	ZFPM2 MICA	2.47e-04	6	121	2	EFO_0801537
Disease	acute chest syndrome (is_implicated_in)	HMOX1 VEGFA	2.47e-04	6	121	2	DOID:1584 (is_implicated_in)
Disease	hepatopulmonary syndrome (biomarker_via_orthology)	HMOX1 VEGFA	2.47e-04	6	121	2	DOID:900 (biomarker_via_orthology)
Disease	gamma-enolase measurement	JMJD1C ZFPM2	2.47e-04	6	121	2	EFO_0021845
Disease	platelet component distribution width	PACSIN1 ITGA2 JMJD1C LIN9 ZFPM2 BRD8 SVIL ADGRF5 MICA HERC1 VEGFA	2.85e-04	755	121	11	EFO_0007984
Disease	Asthma	HLA-DPB1 HMOX1 DNAH5 VEGFA	3.35e-04	80	121	4	C0004096
Disease	retinal ischemia (biomarker_via_orthology)	HMOX1 VEGFA	3.46e-04	7	121	2	DOID:12510 (biomarker_via_orthology)
Disease	cervical cancer	HLA-DPB1 CTNNB1 VEGFA	3.67e-04	34	121	3	C4048328
Disease	Uterine Cervical Neoplasm	HLA-DPB1 CTNNB1 VEGFA	4.00e-04	35	121	3	C0007873
Disease	N-acetylcarnosine measurement	GABRR1 GABRR2	4.59e-04	8	121	2	EFO_0022101
Disease	Dickkopf-related protein 4 measurement	JMJD1C ZFPM2	4.59e-04	8	121	2	EFO_0008110
Disease	neutrophil count	ATF7 C12orf71 HLA-DPB1 ITGAL JMJD1C LIN9 ZFPM2 ADSL CD101 SFXN2 TLN2 ADGRF5 MICA TNR VEGFA	5.42e-04	1382	121	15	EFO_0004833
Disease	Endometrioma	NCOA6 HLA-DPB1 CPM ITGA2 BRD8	5.43e-04	161	121	5	C0269102
Disease	Endometriosis	NCOA6 HLA-DPB1 CPM ITGA2 BRD8	5.43e-04	161	121	5	C0014175
Disease	Graves' disease (is_implicated_in)	C4A C4B VEGFA	5.52e-04	39	121	3	DOID:12361 (is_implicated_in)
Disease	venous thromboembolism, von Willebrand factor measurement	DDX31 ZFPM2 MICA	6.87e-04	42	121	3	EFO_0004286, EFO_0004629
Disease	autistic disorder (is_implicated_in)	GABRR2 FOXP2 C4B	6.87e-04	42	121	3	DOID:12849 (is_implicated_in)
Disease	theophylline measurement	ITGA2 NAV2	7.35e-04	10	121	2	EFO_0021180
Disease	1,7-dimethylurate measurement	FOXP2 ITGA2	7.35e-04	10	121	2	EFO_0021512
Disease	CXCL5 measurement	JMJD1C ZFPM2	7.35e-04	10	121	2	EFO_0009422
Disease	C-X-C motif chemokine 5 measurement	JMJD1C ZFPM2	7.35e-04	10	121	2	EFO_0008058
Disease	fibromuscular dysplasia	ZNF827 SVIL PHACTR1	7.88e-04	44	121	3	EFO_1000938
Disease	response to virus	MCPH1 FREM2	8.95e-04	11	121	2	GO_0009615
Disease	insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation	PTPRO TLN2	8.95e-04	11	121	2	EFO_0004471, EFO_0009131
Disease	heart rate variability measurement, response to antipsychotic drug	COL12A1 NAV2 SAP130	8.98e-04	46	121	3	EFO_0008003, GO_0097332
Disease	dickkopf‐related protein 1 measurement	JMJD1C ZFPM2	1.07e-03	12	121	2	EFO_0010620
Disease	Granulomatosis with Polyangiitis	HLA-DPB1 TENM3	1.26e-03	13	121	2	EFO_0005297
Disease	tetralogy of Fallot (implicated_via_orthology)	ZFPM2 DNAH5	1.47e-03	14	121	2	DOID:6419 (implicated_via_orthology)
Disease	C-X-C motif chemokine 11 measurement	JMJD1C ZFPM2	1.47e-03	14	121	2	EFO_0008057
Disease	phenylalanine measurement	MYBPH SLC17A3 PCDH15	1.51e-03	55	121	3	EFO_0005001
Disease	vascular endothelial growth factor measurement	JMJD1C ZFPM2 VEGFA	1.59e-03	56	121	3	EFO_0004762
Disease	phosphatidylcholine 36:3 measurement	PABPC1 TNR	1.69e-03	15	121	2	EFO_0010381
Disease	brain edema (biomarker_via_orthology)	HMOX1 VEGFA	1.69e-03	15	121	2	DOID:4724 (biomarker_via_orthology)
Disease	docosahexaenoic acid measurement	MCPH1 INCENP JMJD1C MICA	1.89e-03	127	121	4	EFO_0007761
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	JMJD1C ZFPM2	1.93e-03	16	121	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	Astigmatism	CPM MAML2 DNAH5 TNR	2.00e-03	129	121	4	HP_0000483
Disease	platelet-derived growth factor BB measurement	JMJD1C ZFPM2 MICA	2.04e-03	61	121	3	EFO_0008264
Disease	Astrocytosis	ITGA2 TNR	2.18e-03	17	121	2	C3887640
Disease	Graves disease, thyrotoxic periodic paralysis	DCHS2 MICA	2.18e-03	17	121	2	EFO_0004237, MONDO_0019201
Disease	Gliosis	ITGA2 TNR	2.18e-03	17	121	2	C0017639
Disease	neuroticism measurement, cognitive function measurement	FOXP2 JMJD1C TENM3 PTPRO NAV2 ASCC3 TNR EPHB1	2.36e-03	566	121	8	EFO_0007660, EFO_0008354
Disease	Coronary Arteriosclerosis	HMOX1 VEGFA PHACTR1	2.44e-03	65	121	3	C0010054
Disease	Coronary Artery Disease	HMOX1 VEGFA PHACTR1	2.44e-03	65	121	3	C1956346
Disease	Myeloid Leukemia	STAG2 VEGFA	2.44e-03	18	121	2	C0023470
Disease	Leukemia, Monocytic, Chronic	STAG2 VEGFA	2.44e-03	18	121	2	C0023466
Disease	Hemangiosarcoma	CTNNB1 VEGFA	2.44e-03	18	121	2	C0018923
Disease	ulcerative colitis	SATB2 TOM1 C1orf141 NR5A2 MAML2 VEGFA	2.64e-03	335	121	6	EFO_0000729
Disease	venous thromboembolism, fibrinogen measurement	DCHS2 JMJD1C ZFPM2	2.66e-03	67	121	3	EFO_0004286, EFO_0004623
Disease	unipolar depression, bipolar disorder, schizophrenia	DCHS2 FOXP2	3.02e-03	20	121	2	EFO_0003761, MONDO_0004985, MONDO_0005090
Disease	mean platelet volume	ITGA2 JMJD1C LIN9 ZFPM2 BRD8 ZBED4 SVIL ADGRF5 MICA MAML2 SMAD5	3.21e-03	1020	121	11	EFO_0004584
Disease	blood pressure	TNR PHACTR1	3.65e-03	22	121	2	EFO_0004325
Disease	Autosomal Recessive Primary Microcephaly	MCPH1 CEP63	3.65e-03	22	121	2	C3711387
Disease	Morbilliform Drug Reaction	HLA-DPB1 C4B	3.99e-03	23	121	2	C0406537
Disease	Drug Eruptions	HLA-DPB1 C4B	3.99e-03	23	121	2	C0011609

Protein segments in the cluster

Peptide	Gene	Start	Entry
LMQSNMTNTVVRTTL	UMODL1	1046	Q5DID0
MVVMNSLRVILQASP	CA5B	1	Q9Y2D0
TSDMQTIEQESPIMA	ARFGAP3	321	Q9NP61
TMPTVQRKDIQIPMS	C1orf141	271	Q5JVX7
KMRPSTDTITVMVEN	C4B	166	P0C0L5
VESVSQATIVMMPAL	BRD8	301	Q9H0E9
LTKSMDNMTVRVPET	FDX1	156	P10109
TRAHVTPMDQVTTAM	APCDD1L	356	Q8NCL9
MMVLQVSAAPRTVAL	HLA-DPB1	1	P04440
QMASQRTELSMPIQS	ATF7	456	P17544
TVQISLPSTMRMTVA	CA6	86	P23280
LTVPAVDTQMETRPM	EFCAB12	311	Q6NXP0
IQVVSRELRMPMSNV	AOX1	1056	Q06278
PAVSRVMNMKIEETT	ITIH4	706	Q14624
STMVPKMLVNIQTQS	OR7A2P	76	Q8NGA2
TMPVTSILPMDVSQN	RRH	316	O14718
MRPASSQVPRVMSTQ	PABPC1	466	P11940
AVMMVENSRPTLAIN	KIAA0895L	251	Q68EN5
TMPQSSRAQTLAMNV	MICA	151	Q29983
ASMTMNVIQTVPNLD	ANAPC7	186	Q9UJX3
TVPIMHQVSATMRSI	EPHB1	436	P54762
SGMVIRTSQLIPEMQ	MCM4	286	P33991
SPQMVSAIVRTMQNT	CTNNB1	191	P35222
ITMVAMVNSTSPQSQ	SLC17A3	61	O00476
MLETLSQSPQGRVMT	PCBP1	166	Q15365
QRVAMVPQKFTATMS	LIN9	81	Q5TKA1
MMQTLLTVTQNVEVP	MAGED2	26	Q9UNF1
VMTSMPSEKQNVVIQ	MCPH1	651	Q8NEM0
LHTVQRNQMLMTPTS	INCENP	496	Q9NQS7
RNQMLMTPTSAPRSV	INCENP	501	Q9NQS7
MMLTQAPSSVVRSRN	CFAP65	66	Q6ZU64
FTRTMIVMNDQVLEP	JMJD1C	216	Q15652
VKPMNTMAPVVTRNT	FREM2	431	Q5SZK8
SASNKVPAMQRTMRT	ZFPM2	721	Q8WW38
MSTSPQASIIAMEQQ	HERC1	1616	Q15751
SMRNRIQSSPMTVIS	NHSL1	1516	Q5SYE7
LPSSIQSRLSMVNQM	PCNX1	2161	Q96RV3
LELPMVTTIQMSSQL	IFI35	116	P80217
MQMVTEIVVPTVCSL	LCTL	536	Q6UWM7
STRMSQTVQRMLVAA	OR3A1	136	P47881
PTMSTVRMTLRITEN	MUC3A	2546	Q02505
NQRTCNMTVLSMLPT	PEX3	61	P56589
QVPVSVAMMTPQVIT	FOXP2	86	O15409
MRPVTASITTMPVNT	MRTFB	926	Q9ULH7
MSQTETVSRSVAPMR	HEG1	436	Q9ULI3
METTTTFPRVIMQEV	PARM1	236	Q6UWI2
MSSMTSVQKQSIPVL	DDX31	251	Q9H8H2
TSIPNVTEMKTNMSL	ITGA2	101	P17301
VTVPKMLLSMQTQDQ	OR1J4	76	Q8NGS1
FIAVSTMVTEMNPNV	PTPRO	806	Q16827
TMVTEMNPNVVVISV	PTPRO	811	Q16827
VEVSESLSPMTQMLQ	DCHS2	1091	Q6V1P9
MTREMNSKTEQSVTP	PACSIN1	171	Q9BY11
AMTMQRLESSEQRVP	PHACTR1	321	Q9C0D0
SMPPQRTSNVMITSN	MAML2	946	Q8IZL2
DVSLSQMMPDVSIQQ	NCOA6	811	Q14686
QTMCPSEVTNMEITS	PCDH15	1916	Q96QU1
ELMASLDQPTQTVVM	EIF3CL	831	B5ME19
ISSRIPVSSGFMVQM	FAM126A	226	Q9BYI3
VLTMSTIITGVNASM	GABRR1	321	P24046
MIVDNTTMQLVSRPQ	IDH3G	251	P51553
TTMQLVSRPQQFDVM	IDH3G	256	P51553
LQVSLMSRQPQVMLT	CD101	541	Q93033
AQPSERSIMQSQSVM	C1QTNF6	221	Q9BXI9
TNLINSTRIHIMPSM	CPM	111	P14384
GQEMTTLSDTTVMPI	COL12A1	1171	Q99715
TMRVNDLVGTSMTVL	CEP63	231	Q96MT8
QTVPPNSTTMSLSMR	ECSCR	91	Q19T08
VQQAPTVTMVRVVTT	FOXK1	516	P85037
MSEIPSTIVSKNMTN	CFAP100	1	Q494V2
RTVRVAMQVPVVMTS	ELF2	386	Q15723
MTSQPISNETIIMLP	MS4A6E	1	Q96DS6
MNSMTSAVPVANSVL	MS4A8	1	Q9BY19
MNSLEMTPAVRQRVI	HMOX1	186	P09601
MMTAVSLTTRPQESV	KRBOX1	1	C9JBD0
MATAQLQRTPMSALV	HORMAD1	1	Q86X24
VESDMNTVVRVMQLP	DVL1P1	386	P54792
NTATTAMMVPIVEAI	SLC13A5	141	Q86YT5
TTVVKVPMMLQSSTI	SERPINA6	226	P08185
KMRPSTDTITVMVEN	C4A	166	P0C0L4
ANPMDTESTIVMRVL	DNAH5	2171	Q8TE73
VLTMTTIITGVNASM	GABRR2	301	P28476
RTADAEIKMQSMQTP	PRDM2	1516	Q13029
MEPQNTTQVSMFVLL	OR4D1	1	Q15615
MSQVIQAMPSDLTIS	NR5A2	196	O00482
LMSQASRPEQSVMQA	MIDN	106	Q504T8
IMVQSASPDIRVTRM	KIF13B	1491	Q9NQT8
NMTVTMVANLVPFTL	TAS2R43	176	P59537
TQVVISRITMSAPGM	SFXN2	226	Q96NB2
VQMVTTTPIPQMEAR	SSPOP	2341	A2VEC9
DVTRMVSMPQTTAGT	SVIL	1711	O95425
SRTPETVRMVLSNME	IMPA1	166	P29218
LMTLVMDPLQTASVQ	ADSL	311	P30566
VTQMSLSNPTMLRTH	NAV2	1576	Q8IVL1
RSQPSVSQMGMRQTS	SATL1	511	Q86VE3
ERERSMNPNVSMVSS	SATB2	436	Q9UPW6
SQDRLLPMTVVTMAS	MAPKAP1	186	Q9BPZ7
LPMTVVTMASARVQD	MAPKAP1	191	Q9BPZ7
SARPMMVTQQTVRNL	MYBPH	121	Q13203
QMIVLSSRPVVDMVT	ITGAL	606	P20701
NIAAMLPRETQITTM	STK32A	166	Q8WU08
MTPMKRSVQTQVSEP	SLFNL1	1	Q499Z3
NMIPQIMPSISSRDV	SMAD5	246	Q99717
STVPTQVNSEMMTHV	ADGRF5	781	Q8IZF2
SVMMEASIQPITRTV	ASCC3	1181	Q8N3C0
SPPEMVQMISQATAS	C12orf71	166	A8MTZ7
SIMQESIRVNPSMVT	WASHC5	566	Q12768
VTVAAAMSMRSPVNV	VEZF1	416	Q14119
AMSMRSPVNVSSAVN	VEZF1	421	Q14119
PVTQQMTEMSISRED	ZFAND5	96	O76080
NRMIVVTPNRTMSDF	MIOS	336	Q9NXC5
ITMVPSETQSNNEMS	MUC13	131	Q9H3R2
MQTPQLTSTIMREPK	STAG2	1116	Q8N3U4
TVMPTTQVESQEAMQ	TPR	1716	P12270
VRVMSEMLTELVPTQ	TOM1	231	O60784
ETTSVAIQTMLRQIM	RLIM	396	Q9NVW2
VASTVHLNPMQLMTV	SAP130	536	Q9H0E3
ISAVMNSQQSVPATM	TNR	666	Q92752
AITMPSVARHTMQTI	TENM3	1891	Q9P273
SRTPDTISDQTQMMV	USF3	1361	Q68DE3
TISDQTQMMVSQIPP	USF3	1366	Q68DE3
NIAQRSQSVPLTVMM	RFX7	1121	Q2KHR2
ELVGTMMTSNTPERT	ZNF827	496	Q17R98
PVEAMVTILMRAINS	WRNIP1	381	Q96S55
MVTLQMPSVAAQTSL	ZNF613	571	Q6PF04
AVTAQEMMTKSVTNP	TLN2	1866	Q9Y4G6
PLMDTLSSMNRVQQV	UBR7	356	Q8N806
LPVATIQNASTAMLM	ZNF687	401	Q8N1G0
VEMMPSRNTLSQEVE	ZNF407	346	Q9C0G0
DPTAMMQQLLTTSRQ	YEATS4	146	O95619
PTEESNITMQIMRIK	VEGFA	96	P15692
PKMQTMAVSVTSILA	ZYG11A	481	Q6WRX3
MADTQTQVAPTPTMR	XIRP1	1	Q702N8
TQVAPTPTMRMATAE	XIRP1	6	Q702N8
SMPMSEVSQVSRAAQ	THEG	246	Q9P2T0
EMSTQMSTLSQVIPM	ZBED4	946	O75132
AIISVISVCMNTPMT	NALCN	46	Q8IZF0